Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-01399 | Eribulin Mesylate | 441045-17-6 |
| Eribulin Mesylate is an antitumor drug that can be used to treat patients with metastatic breast cancer. It inhibits the proliferation of cancer cells by binding tubulin and microtubules. Eribulin Mesylate can inhibit experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states. | Inquiry |
